Headache disorders are revealed as one of the major global public-health concerns. In 2019, migraine disease was second among the causes of disability and first among women under 50 years of age (1A). The prevalence of migraine is estimated to be 12% in the United States with approximately 23% of households having at least one family member with migraine.
Download the PDF by AbbVie Medical to see how acute migraine treatment can help provide rapid and consistent relief for those suffering from chronic migraine.
Download Insight
